FindTrial
Sign In

A Prospective Open-Label Treatment Trial of Asenapine Monotherapy in subjects at Clinical High Risk for Psychosis

A Prospective Open-Label Treatment Trial of Asenapine Monotherapy in subjects at Clinical High Risk for Psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-14005047
Enrollment
Unknown
Registered
2014-08-04
Start date
2009-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis

Interventions

art risk patients:asenapine

Sponsors

secretaria de ciencia y tecnica UNR
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
16 Years to 24 Years

Inclusion criteria

Inclusion criteria: age 15-24 years Criteria of Prodromal Syndromes

Exclusion criteria

Exclusion criteria: (1) previous diagnosis of any psychotic disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (2) symptoms fully accounted for by an Axis 1 disorder or consequences of drug/alcohol use (3) abuse of alcohol or drugs (4) antipsychotic medication use

Design outcomes

Primary

MeasureTime frame
transition rate;—

Countries

argentina

Contacts

Public Contactserrani daniel
danielserrani@argentina.com+543415769678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026